In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes

International Journal of Artificial Organs

Volumn 20, Issue 11, 1997, Pages 603-609

  Mandolfo, S ^a   Tetta, C ^b   David, S ^c   Gervasio, R ^b   Ognibene, D ^b   Wratten, M L ^b   Tessore, E ^b   Imbasciati, E ^a,d  

^a Dept of Nephrology and Hemodialysis ^*  (Italy)

^b Cyberonics Inc   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

^d Ospedale Provinciale Maggiore   (Italy)

Author keywords

Biocompatibility; Cellulose; Complement; Cytokines; Leukocyte adherence

Indexed keywords

BIOCOMPATIBILITY; BODY FLUIDS; CELL ADHESION; DIALYSIS; METABOLISM; ORGANIC ACIDS; PATIENT TREATMENT; UREA;

COMPLEMENT; CYTOKINES; IN-VITRO; IN-VIVO; LEUCOPENIA; LOW FLUX; POLYSULPHONE; RECIRCULATIONS; URIC ACIDS; VIVO STUDIES;

CELLULOSE;

ACETIC ACID DERIVATIVE; BENZYL DERIVATIVE; CELLULOSE; COMPLEMENT COMPONENT C3A; CYTOKINE; POLYSULFONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BIOCOMPATIBILITY; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; DIALYSIS MEMBRANE; HEMODIALYSIS; HEMOPERFUSION; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; LEUKOCYTE COUNT; LEUKOPENIA; THROMBOCYTE COUNT;

EID: 0031464422     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139889702001102     Document Type: Article

References (13)

1. Kazatchkine M, Haeffner-Cavaillon N. Mechanisms and consequences of complement activation during hemodialysis. Adv Exp Med Biol 1989; 260:19-26.
2. Harlan JM, Lin DY. Adhesion: its role in inflammatory disease. New York: Freeman, 1992.
3. Tetta C, Tropea F, Camussi G, et al. Adherence of human monocytes to haemodialysis membranes: LFA1 (CD11a/CD18) CR1 (CD35) and CR3 (CD11b/CD18) triggering promotes the biosynthesis of platelet-activating factor and adherence. Nephrol Dial Transplant 1995; 10: 1679-88.
4. David S, Tetta C, Camussi G, et al. Adherence of human monocytes to haemodialysis membranes. Nephrol Dial Transplant 1993; 8: 1223-7.
5. Klinkmann H, Davison AM, eds. Consensus conference on biocompatibility. Nephrol Dial Transplant 1994; 9 (suppl 2).
6. Vienken J, Diamantoglou M, Hahn C, Kamusewitz H, Paul D. Considerations on developmental aspects of biocompatible dialysis membranes. Artif Organs 1995; 19 (5): 398-406.
7. Camussi G, Pacitti A, Tetta C, et al. Mechanisms of neutropenia in hemodialysis. ASAIO Trans 1984; XXX: 364-9.
8. Connolly DTT, Knight MB, Harakas MK, Witwer AJ, Feder J. Determination of the number of endothelial cells in culture using an acid phosphatase assay. Anal Biochem 1986; 152: 136-40.
9. De Filippi P. Vantiinsbergh V, Bertolotto A, Rossino P, Silengo L, Tarone G. Differential distribution and modulation of expression of α1/B1 integrin on human endothelial cells. J Cell Biol 1991; 114 (4): 855-63.
10. Ward R, Klein E, Harding G. Murchison K. Response of complement and neutrophils to hydrophilized synthetic membranes. ASAIO Trans 1989; 34: 334-7.
11. Bohler J, Donauer J, Schollmeyer P, Horl WH. Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation. J Am Soc Nephrol 1996; 7: 234-41.
12. Tetta C, Cioni A, Camussi G. Biocompatibility: still a challenge. J Nephrol 1991; 5 (1): 14-22.
13. Ward R, Buscaroli A, Schmidt B, et al. A comparison of dialysers with low-flux membranes: significant differences in spite of many similarities. Nephrol Dial Transplant 1997; 12: 965-72.